Communicating about Risks and Safe Use of Medicines
Springer Verlag, Singapore
978-981-15-3012-8 (ISBN)
Priya Bahri holds degrees in pharmacy and epidemiology, focused her PhD at Humboldt University of Berlin on healthcare quality management, and is trained in strategic communication and global health diplomacy. She worked in pharmacies and for projects of health insurance physicians’ associations and the German international development agency before joining the European Medicines Agency (EMA) in 1996 and specialising in pharmacovigilance. She is active for the Utrecht WHO Collaborating Centre for Pharmaceutical Policy and Regulation and also in learned societies, including as fellow of the International Society of Pharmacovigilance.
ForewordBaruch Fischhoff
Preface: Guide for readersPriya Bahri
Authors’ biographical notes
Overview of contents in chapters
1. A multilayered research framework for humanities and epidemiology of medicinal product risk communicationPriya Bahri
Part I: Medicines in real life as communication challenges2. Hormonal contraceptives - Communication for risk awareness and informed choice, or a public scare?Barbara Mintzes, Teresa Alves, with a contribution from Priya Bahri
3. COX-2 inhibitors - Communication of accumulating risk evidence and a product withdrawalAmy Rogers, Kerr Grieve, Thomas M MacDonald, with a contribution from Sérgio Nishioka
4. Isotretinoin - Communication for preventing birth defects and alerting of an uncertain risk of suicideIneke (HJMJ) Crijns
5. Pandemic influenza vaccines - Communication of benefits, risks and uncertaintiesGlen J Nowak, Emilie Karafillakis, Heidi Larson
Part II: Tackling the challenges – Methods for medicinal product risk communication research6. Ethical frameworksGhislaine van Thiel
7. The cognitive and behavioural sciencesSara Rubinelli, Nicola Diviani, Maddalena Fiordelli 8. The social sciencesBrian Taylor, Anne Moorhead
9. Rhetoric and science & technology studiesMathias Møllebæk
10. Media science and practiceGlen J Nowak, Michael A Cacciatore
11. Social media researchNabarun Dasgupta, Carly Winokur, Carrie E Pierce
12. Design science with a focus on user-centred evaluation of written informationJörg Fuchs
13. Dissemination & implementation scienceElaine Morrato, Meredith Smith
14. PharmacoepidemiologyBert (HGM) Leufkens
15. Legal frameworksBurkhard Sträter
16. From passive to active - Patients as contributors to medicinal product risk communication researchFrançois Houÿez
Afterword: The dimension of communicating medicine risks in low- and middle-income countriesNilima A Kshirsagar
Erscheinungsdatum | 29.06.2020 |
---|---|
Zusatzinfo | 30 Illustrations, color; 2 Illustrations, black and white; XXX, 504 p. 32 illus., 30 illus. in color. |
Verlagsort | Singapore |
Sprache | englisch |
Maße | 155 x 235 mm |
Gewicht | 1060 g |
Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Pharmakologie / Pharmakotherapie |
Medizin / Pharmazie ► Pharmazie | |
Schlagworte | Health Communication • Medical Humanities • Patient-Centred Care • pharmacoepidemiology • pharmacovigilance • Risk Management • Risk Perception • Vaccine safety |
ISBN-10 | 981-15-3012-2 / 9811530122 |
ISBN-13 | 978-981-15-3012-8 / 9789811530128 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
aus dem Bereich